Anebulo Pharmaceuticals (ANEB) Assets (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) reported Assets of $9.42 million for fiscal Q2 2026 (quarter ended Dec 31, 2025), down 40.5% from $15.84 million a year earlier and down 12.0% from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Assets (2020 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Anebulo Pharmaceuticals posted Assets of $12.15 million, up 198.2% from FY2024.
- Assets has a five-year compound annual growth rate of 32.0% (FY2020 to FY2025).
- By fiscal year, Assets came in at $4.07 million in FY2024 (-65.1%), $11.67 million in FY2023 (-25.1%), $15.58 million in FY2022 (-28.1%) and $21.65 million in FY2021 (+615.0%).
- The fiscal Q2 2026 figure ranks as the lowest quarterly Assets since fiscal Q1 2025.
- Year over year, Assets gained in four of the last eight quarters, with growth averaging 67.5%.
- The high point for year-over-year Assets in five years was fiscal Q4 2021 (growth of 615.0%); the low point was fiscal Q1 2025 (a decline of 72.7%).
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $10.7 million (Q1 2026), $12.15 million (Q4 2025) and $14.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | 9.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.42 Mn |
| Sep 30, 2025 | 10.70 Mn |
| Jun 30, 2025 | 12.15 Mn |
| Mar 31, 2025 | 14.01 Mn |
| Dec 31, 2024 | 15.84 Mn |
| Sep 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 4.07 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | 7.50 Mn |
| Sep 30, 2023 | 9.05 Mn |
| Jun 30, 2023 | 11.67 Mn |
| Mar 31, 2023 | 14.43 Mn |
| Dec 31, 2022 | 16.89 Mn |
| Sep 30, 2022 | 19.82 Mn |
| Jun 30, 2022 | 15.58 Mn |
| Mar 31, 2022 | 17.25 Mn |
| Dec 31, 2021 | 18.96 Mn |
| Sep 30, 2021 | 20.50 Mn |
| Jun 30, 2021 | 21.65 Mn |
| Mar 31, 2021 | 4.29 Mn |
API Access
Anebulo Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();